Interim FDA Chief on Leave From Day Job
- Share via
From Times Wire Reports
Andrew von Eschenbach, named last week as interim Food and Drug Administration commissioner to replace Lester Crawford, will take a leave of absence from his job as director of the National Cancer Institute, Sen. Barbara Mikulski said.
Von Eschenbach also will “refrain from selected FDA activities that may be seen as a conflict of interest,” Mikulski, a Maryland Democrat, said in a statement.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
